IP AUSTRALIA
AUSTRALIAN PATENT OFFICE
Cytec Industries Inc. v Nalco Company [2018] APO 4
Patent Application: 2012220990
Title:Reducing aluminosilicate scale in the Bayer process
Patent Applicant: Nalco Company
Opponent: Cytec Industries Inc.
Delegate: Dr D.A.S. Beck
Decision Date: 16 January 2018
Hearing Date: 19 October 2017 in Sydney
Catchwords: PATENTS - opposition under section 104 – allowability under sections 102(1) and 102(2) considered – as a result of the amendment, the specification would claim or disclose matter that extends beyond that disclosed in the complete specification and abstract as filed – as a result of the amendment, specification does not provide a clear enough and complete enough disclosure of all things that fall within the scope of the claims – as a result of the amendment, claims lack support insofar as they embrace isolated compounds in the absence of the other components of the complex mixtures in which their production was enabled – opposition successful – amendment refused – costs awarded against the applicant.
Representation: Patent attorney for the applicant: Dr Gareth Dixon, Shelston IP
Patent attorney for the opponent: Dr Linda Govenlock, Allens Patent and Trademark Attorneys
IP AUSTRALIA
AUSTRALIAN PATENT OFFICE
Patent Application: 2012220990
Title:Reducing aluminosilicate scale in the Bayer process
Patent Applicant: Nalco Company
Date of Decision: 16 January 2018
DECISION
The amendment is refused. Costs are awarded against the applicant.
REASONS FOR DECISION
The present opposition is governed by the Patents Act 1990 (the Act) as amended by the
Intellectual Property Laws Amendment (Raising the Bar) Act 2012 (the Raising the Bar Act).
Amendments to sections 40 and 102 of the Act apply to the present case as a consequence of
Schedule 1, items 55(1)(e) and 55(9)(e) of the Raising the Bar Act – the applicant had not asked
for examination before 15 April 2013 (the request for examination was filed on 21 August
2013).Background
Patent application 2012220990 (the application) was filed by Nalco Company (the applicant) on 7 February 2012 under the provisions of the PCT, claiming an earliest priority date of 25 February 2011. The application was accepted on 1 May 2015, and its acceptance published in the Official Journal on 21 May 2015.
Cytec Industries (the opponent) filed a Notice of Opposition to grant of a patent under section 59 of the Act on 21 August 2015 and a statement of grounds and particulars (SGP) on 23 November 2015. Evidence in support and answer in the section 59 opposition was completed by 25 May 2016.
On 25 May 2016, the applicant filed a request to amend the specification under section 104 (the amendments). On 15 June 2016, pursuant to regulation 5.22 the opponent requested a direction from the Commissioner for a stay of the section 59 opposition on the grounds that the status of the amendments should be settled before the opponent is required to file their evidence in reply in regards to the section 59 matter.
On 17 June…
Keep reading for free
Create a free CaseChat account to read Cytec Industries Inc. v Nalco Company and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2018] APO 4
- Decision Date
CaseChat Overview and Summary
The central legal issues before the court were whether the amended patent specification met the disclosure requirements under sections 102(1) and 102(2) of the Act, and whether the claims made by Nalco Company were sufficiently supported by the disclosure. Specifically, the court had to determine whether the amendments led to a specification that either extended beyond the original disclosure or failed to provide a clear and complete disclosure of the invention. Additionally, the court examined whether the claims for isolated compounds were adequately supported in light of the specification's disclosure.
The court found that the amendments to the patent specification resulted in a disclosure that extended beyond what was originally filed, thereby not meeting the requirements of section 102(1). It was further determined that the amended specification did not provide a clear and complete disclosure of all aspects of the invention as required by section 102(2). The court concluded that the claims for isolated compounds lacked support as they did not align with the disclosure of the complex mixtures in which their production was enabled. Consequently, the opposition was upheld, the patent amendment was refused, and costs were awarded against the applicant, Nalco Company.
The Federal Court of Australia ruled in favour of Cytec Industries Inc., granting the opposition and refusing the patent amendment. The court ordered that Nalco Company pay the costs associated with the opposition proceedings.
Orders
Orders of the court
Full text does not contain this section.
Background
Background to the litigation
Full text does not contain this section.
Evidence
Evidence Before The Court
Full text does not contain this section.
Decision
Reasons for decision
Full text does not contain this section.
Ratio Decidendi
Legal Principle Established
Full text does not contain this section.